SIRT6 and head and neck squamous cell carcinoma: Sirt1 expression was elevated, whereas Sirt6 expression was reduced, when the Sirt6-overexpressing HNSCC cells were treated with the 26S proteasome inhibitor MG-132 (Fig. 5a).